Drawing for ONZETRA

USPTO serial 79093821

ONZETRA

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
SOUDERS, MICHAEL J
Law office
MADRID PROCESSING UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONZETRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

Bassam N. Ibrahim Buchanan Ingersoll & Rooney, PCP.O. Box 1404Alexandria, VA 22313-1404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, tablets, granules, pills, sachets, powders, and capsules, all for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized painSECTION 70 - CANCELLED
040Treatment of materials, namely, milling, grinding, mixing, compressing and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions for use in the pharmaceutical and medical industriesSECTION 70 - CANCELLED
041Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses in the field of medicine, health and pharmaceuticalsSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2011DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 9, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2011LIMGLIMITATION OF GOODS RECEIVED FROM IB
Oct 28, 2011LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 22, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 17, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2011XAECEXAMINER'S AMENDMENT ENTERED
Oct 17, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 17, 2011GNEAEXAMINERS AMENDMENT E-MAILED
Oct 17, 2011CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 15, 2011LIMGLIMITATION OF GOODS RECEIVED FROM IB
Sep 30, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2011ALIEASSIGNED TO LIE
Sep 19, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2011RFNTREFUSAL PROCESSED BY IB
Mar 25, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2011RFRRREFUSAL PROCESSED BY MPU
Mar 24, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2011DOCKASSIGNED TO EXAMINER
Mar 22, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Mar 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance